Abstract
Use of biomarkers may help reduce inhaled corticosteroid burden in severe asthma if treatment advice is followed. T2 low asthma is less common than previously thought. https://bit.ly/3rG7SZ2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have